Treatment of Blepharospasm with Methylphenidate: A Telemedicine Study
Movement Disorders Clinical Practice · 2025
DOI: 10.1002/mdc3.70485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Mehreen Thayani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Emory University, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Methylphenidate, Blepharospasm, Central Nervous System Stimulants. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institutes of Health (NIH), NINDS NIH HHS, Dystonia Coalition.
Abstract (Originalsprache)
Background
The treatment of choice for blepharospasm and related craniofacial dystonias involves local injection of botulinum toxins. However, some individuals report incomplete or short‐duration responses, so additional therapies are sometimes needed.
Objective
To assess the potential value of methylphenidate as an add‐on therapy in this population.
Methods
Six individuals with craniofacial dystonia were given trials of methylphenidate. Videos were collected via a telemedicine platform before and after treatment, and four clinicians applied five different rating scales to score severity blinded to treatment state. Patients also were asked to provide their subjective impressions of any change in their condition, and a computer vision tool was applied to the videos to estimate overall change in eye open‐ness.
Results
Five of six individuals reported improvements with methylphenidate. The improvements were corroborated with blinded clinician‐rated scales and computer vision.
Conclusions
Methylphenidate can provide at least partial relief of symptoms in craniofacial dystonias.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Emory University, Atlanta, GA, USA.
- Department of Neurology, Medical University of South Carolina, Charleston, SC, USA.
- Department of Human Genetics, Emory University, Atlanta, GA, USA.
- Department of Pediatrics, Emory University, Atlanta, GA, USA.
ORCID-Profile: Mehreen Thayani, Laura M Scorr, H A Jinnah
Förderung
- National Institutes of Health (NIH)
- NINDS NIH HHS
- Dystonia Coalition
- NCATS NIH HHS
Zitieren
APA
Thayani, M., Lopez-Castellanos, R., Nalamada, K., Dinasarapu, A. R., Kilic-Berkmen, G., Scorr, L. M., & Jinnah, H. A. (2025). Treatment of Blepharospasm with Methylphenidate: A Telemedicine Study. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70485
Vancouver
Thayani M, Lopez-Castellanos R, Nalamada K, Dinasarapu AR, Kilic-Berkmen G, Scorr LM, et al. Treatment of Blepharospasm with Methylphenidate: A Telemedicine Study. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70485
BibTeX
@article{Thayani2025,
author = {Thayani, Mehreen and Lopez-Castellanos, Ricardo and Nalamada, Keerthana and Dinasarapu, Ashok R and Kilic-Berkmen, Gamze and Scorr, Laura M and Jinnah, H A},
title = {Treatment of Blepharospasm with Methylphenidate: A Telemedicine Study},
journal = {Movement Disorders Clinical Practice},
year = {2025},
doi = {10.1002/mdc3.70485}
}
EUVIMED